News for Celltrion Healthcare Co., Ltd. (091990.KQ)

On October 23rd, at the EGM of shareholders, the merger agreement between Celltrion, Inc. & Celltrion Healthcare Co., Ltd. was approved Celltrion Group’s…

/PRNewswire/ -- Allied Market Research published a report, titled, "Biosimilar Monoclonal Antibody Market by Type (Adalimumab, Bevacizumab, Infliximab,...

/PRNewswire/ -- The "Biosimilars Market Size, Share & Trends Analysis By Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins), By...

Asia- Pacific is fastest growing region in the gastrointestinal drugs market; which was valued at $8,868.44 million in 2019 and is projected to reach...

/PRNewswire/ -- The "Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin,...

The global gastric cancer market is anticipated to grow tremendously by 2031, mainly due to an increasing prevalence of gastric cancer among people. Also,...

/PRNewswire/ -- The biologic therapeutics market size is forecasted to increase by USD 286.12 billion from 2022 to 2027 at a CAGR of 11.34%, according to a...

/PRNewswire/ -- The protein therapeutics market size is forecast to increase by USD 153.56 billion from 2022 to 2027, at a CAGR of 9.14%, according to the...

Increase in the occurrence of gastric cancer across the globe, the rising incidence of gastric cancer, surge in obesity and overconsumption of highly...

/PRNewswire/ -- The "Stomach Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Treatment Type,...

Visiongain has published a new report entitled Biosimilars and Follow-on Biologics 2023-2033. It includes profiles of Biosimilars and Follow-on Biologics...

Visiongain has published a new report entitled Biosimilars and Follow-on Biologics 2023-2033. It includes profiles of Biosimilars and Follow-on Biologics...